Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic Adjuvants in Colorectal Cancer Surgery
NCT05742438Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in colorectal cancer (CRC) comparing Lidocaine Group, Dexmedetomidine Group and Intrathecal Morphine Group (3 arms). Primary endpoint: Matrix Metallopeptidase 9. Started Apr 2023; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinedexmedetomidinemorphine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05742438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05742438.